Although an investigation of the pathological roles of blood ASM-mediated immune cell dysregulation in other neurological disorders is warranted, a therapeutic strategy targeting blood ASM could be helpful in the prevention and treatment of neurological disorders. The gene discussed is SMPD1; the disease is nervous system disorder.